SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021513
Filing Date
2023-05-12
Accepted
2023-05-12 08:31:57
Documents
71
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q impl-20230331.htm   iXBRL 10-Q 2343911
2 EX-31.1 impl-ex31_1.htm EX-31.1 20849
3 EX-31.2 impl-ex31_2.htm EX-31.2 20883
4 EX-32.1 impl-ex32_1.htm EX-32.1 9770
5 EX-32.2 impl-ex32_2.htm EX-32.2 10137
  Complete submission text file 0000950170-23-021513.txt   8511601

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT impl-20230331.xsd EX-101.SCH 74433
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT impl-20230331_lab.xml EX-101.LAB 596955
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT impl-20230331_cal.xml EX-101.CAL 48130
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT impl-20230331_pre.xml EX-101.PRE 434697
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT impl-20230331_def.xml EX-101.DEF 243166
65 EXTRACTED XBRL INSTANCE DOCUMENT impl-20230331_htm.xml XML 1300772
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 10-Q | Act: 34 | File No.: 001-40353 | Film No.: 23913375
SIC: 2834 Pharmaceutical Preparations